Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease

Gilles Duvoisin; Robert N. Lopez; Andrew S. Day; Daniel A. Lemberg; Richard B. Gearry; Steven T. Leach

doi:10.1155/2017/1936315

Mediators of Inflammation (Jan 2017)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease

Gilles Duvoisin,
Robert N. Lopez,
Andrew S. Day,
Daniel A. Lemberg,
Richard B. Gearry,
Steven T. Leach

Affiliations

Gilles Duvoisin: Department of Paediatrics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Robert N. Lopez: Department of Gastroenterology, Sydney Children’s Hospital Randwick, Sydney, Australia
Andrew S. Day: Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand
Daniel A. Lemberg: Department of Gastroenterology, Sydney Children’s Hospital Randwick, Sydney, Australia
Richard B. Gearry: Department of Paediatrics, University of Otago, Christchurch, Christchurch, New Zealand
Steven T. Leach: School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW, Australia

DOI: https://doi.org/10.1155/2017/1936315
Journal volume & issue: Vol. 2017

Abstract

Read online

There is increasing importance placed upon noninvasive assessment of gut inflammation. These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions. Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility. This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.

Published in Mediators of Inflammation

ISSN: 0962-9351 (Print); 1466-1861 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Pathology
Website: https://onlinelibrary.wiley.com/journal/4792

About the journal